サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：経腸栄養剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1342978

経腸栄養剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Enteral Feeding Formulas Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 235 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
経腸栄養剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 235 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経腸栄養剤市場の世界需要は、調査期間2023年～2030年のCAGR7.72%で、2022年の96億2,000万米ドルから2030年にはほぼ187億9,000万米ドルの市場規模に達すると推定されます。

経腸栄養剤は、がん、摂食障害、慢性疾患、生命を脅かす怪我、脳卒中や発作などの医学的疾患のために考慮される経管栄養剤としても知られています。経腸栄養という用語は、胃腸管を通して食物を摂取する手順を表しています。胃、食道、腸、口が消化管を構成します。チューブを介して摂取された栄養は、胃と小腸に直接送られます。この形態の栄養補給法は補助的に用いられます。この栄養補給法により、患者は胃腸の活動を維持する栄養を摂取することができます。

市場力学：

経腸栄養剤市場の堅調な成長は、がん、認知症、脳卒中、多発性硬化症、慢性閉塞性肺疾患（COPD）、肝臓疾患、その他の慢性疾患の有病率の増加が背景にあります。早産児の増加も市場成長を増大させる主要因です。がん領域における経腸栄養剤の需要は、がん罹患率の上昇、病院から外来患者への移行、がん患者の間で非経口栄養剤の効率的な代替品として経腸栄養剤が受け入れられつつあることなどが要因です。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは経腸栄養剤の世界市場における各セグメントを包括的に評価することもできます。 経腸栄養剤産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの 経腸栄養剤市場の現在と将来の需要を強調する地域展望をカバーします。さらに、すべての主要地域における個々の用途セグメントの需要、推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 経腸栄養剤- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 経腸栄養剤の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 標準的なミルク
  • 疾患特異的フォーミュラ

第7章 経腸栄養剤の世界市場分析：フロータイプ別

  • フロータイプ別概要
  • 実績データと予測データ
  • フロータイプ別分析
  • 間欠栄養フロー
  • 連続栄養フロー

第8章 経腸栄養剤の世界市場分析：ステージ別

  • ステージ別概要
  • 実績データと予測データ
  • ステージ別分析
  • 成人
  • 小児

第9章 経腸栄養剤の世界市場分析：適応症別

  • 適応症別概要
  • 実績データと予測データ
  • 適応症別分析
  • アルツハイマー
  • 栄養不足
  • がん治療
  • 糖尿病
  • 慢性腎臓病
  • 希少疾患
  • 嚥下障害
  • 疼痛管理
  • 吸収不良/胃腸障害/下痢
  • その他

第10章 経腸栄養剤の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院（循環器科、神経科、クリティカルケア（ICU）、腫瘍科、その他）
  • 在宅ケア

第11章 経腸栄養剤の世界市場分析：販売チャネル別

  • 販売チャネル別概要
  • 実績データと予測データ
  • 販売チャネル別分析
  • オンライン販売
  • 施設販売
  • 小売販売

第12章 経腸栄養剤の世界市場売上分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第13章 経腸栄養剤企業の競合情勢

  • 経腸栄養剤市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品発売
  • その他の開発

第14章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Abbott
  • Danone SA
  • Fresenius Kabi
  • Nestle
  • Victus Inc.
  • Primus Pharmaceuticals Inc.
  • Meiji Holdings. Co. Ltd
  • Rickett Benckiser Group Plc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Standard Formula Market Sales by Geography (USD MN)
  • Disease-specific Formula Market Sales by Geography (USD MN)
  • Analysis Market by Flow Type (USD MN)
  • Intermittent Feeding Flow Market Sales by Geography (USD MN)
  • Continuous Feeding Flow Market Sales by Geography (USD MN)
  • Analysis by Stage (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Alzheimer's Market Sales by Geography (USD MN)
  • Nutrition Deficiency Market Sales by Geography (USD MN)
  • Cancer Care Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Chronic Kidney Diseases Market Sales by Geography (USD MN)
  • Orphan Diseases Market Sales by Geography (USD MN)
  • Dysphagia Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Market Sales by Geography (USD MN)
  • Home Care Market Sales by Geography (USD MN)
  • Analysis by Sales Channel (USD MN)
  • Online Sales Market Sales by Geography (USD MN)
  • Institutional Sales Market Sales by Geography (USD MN)
  • Retail Sales Market Sales by Geography (USD MN)
  • Global Enteral Feeding Formulas Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Enteral Feeding Formulas Report
  • Market Research Process
  • Market Research Methodology
  • Global Enteral Feeding Formulas Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Flow Type
  • Market Attractiveness Analysis by Stage
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Sales Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Standard Formula Market Sales by Geography (USD MN)
  • Disease-specific Formula Market Sales by Geography (USD MN)
  • Global Market Analysis by Flow Type (USD MN)
  • Intermittent Feeding Flow Market Sales by Geography (USD MN)
  • Continuous Feeding Flow Market Sales by Geography (USD MN)
  • Global Market Analysis by Stage (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Alzheimer's Market Sales by Geography (USD MN)
  • Nutrition Deficiency Market Sales by Geography (USD MN)
  • Cancer Care Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Chronic Kidney Diseases Market Sales by Geography (USD MN)
  • Orphan Diseases Market Sales by Geography (USD MN)
  • Dysphagia Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Market Sales by Geography (USD MN)
  • Home Care Market Sales by Geography (USD MN)
  • Global Market Analysis by Sales Channel (USD MN)
  • Online Sales Market Sales by Geography (USD MN)
  • Institutional Sales Market Sales by Geography (USD MN)
  • Retail Sales Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219148

The global demand for Enteral Feeding Formulas Market is presumed to reach the market size of nearly USD 18.79 BN by 2030 from USD 9.62 BN in 2022 with a CAGR of 7.72% under the study period 2023 - 2030.

Enteral feeding formulas are also known as tube feeding formula considered for medical ailments such as cancer, eating inability, chronic illness, life-threatening injuries, and stroke or attacks. The term enteral feeding describes a procedure in which food is intake through the gastrointestinal tract. The stomach, esophagus, intestines, and mouth constitute the gastrointestinal tract. The nutrition taken via a tube goes directly to the stomach & small intestine. This form of feeding method is used as a supplement. This feeding method enables patients to receive the nutrition that keeps their gastrointestinal tract active.

MARKET DYNAMICS:

The robust growth of the enteral feeding formula market is driven by the increasing prevalence of cancer, dementia, stroke, multiple sclerosis, chronic obstructive pulmonary disease (COPD), liver ailments and other chronic diseases. The rise in preterm births is another major factor augmenting the market growth. The demand for enteral feeding formulas in oncological applications is likely to be fueled by the rising incidence of cancer, the transition from hospitals to outpatient care settings, and the growing acceptance of enteral feeding formulas as an efficient substitute for parenteral nutrition among cancer patients.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of enteral feeding formulas. The growth and trends of enteral feeding formulas industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the enteral feeding formulas market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Standard Formula
  • Disease-Specific Formula

By Flow Type

  • Intermittent Feeding Flow
  • Continuous Feeding Flow

By Stage

  • Adult
  • Pediatric

By Indication

  • Alzheimer'S
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By End-User

  • Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others)
  • Home Care

By Sales Channel

  • Online Sales
  • Institutional Sales
  • Retail Sales

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Enteral Feeding Formulas market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the enteral feeding formulas market include Abbott, Danone SA, Fresenius Kabi, Nestle, Victus, Inc., Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd and Rickett Benckiser Group Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ENTERAL FEEDING FORMULAS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Flow Type
    • 3.7.3 Market Attractiveness Analysis By Stage
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By End-user
    • 3.7.6 Market Attractiveness Analysis By Sales Channel
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Standard Formula Historic and Forecast Sales by Regions
  • 6.5 Disease-specific Formula Historic and Forecast Sales by Regions

7 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY FLOW TYPE

  • 7.1 Overview by Flow Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Flow Type
  • 7.4 Intermittent Feeding Flow Historic and Forecast Sales by Regions
  • 7.5 Continuous Feeding Flow Historic and Forecast Sales by Regions

8 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY STAGE

  • 8.1 Overview by Stage
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Stage
  • 8.4 Adult Historic and Forecast Sales by Regions
  • 8.5 Pediatric Historic and Forecast Sales by Regions

9 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY INDICATION

  • 9.1 Overview by Indication
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Indication
  • 9.4 Alzheimer's Historic and Forecast Sales by Regions
  • 9.5 Nutrition Deficiency Historic and Forecast Sales by Regions
  • 9.6 Cancer Care Historic and Forecast Sales by Regions
  • 9.7 Diabetes Historic and Forecast Sales by Regions
  • 9.8 Chronic Kidney Diseases Historic and Forecast Sales by Regions
  • 9.9 Orphan Diseases Historic and Forecast Sales by Regions
  • 9.10. Dysphagia Historic and Forecast Sales by Regions
  • 9.11 Pain Management Historic and Forecast Sales by Regions
  • 9.12 Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales by Regions
  • 9.13 Others Historic and Forecast Sales by Regions

10 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY END-USER

  • 10.1 Overview by End-user
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-user
  • 10.4 Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Historic and Forecast Sales by Regions
  • 10.5 Home Care Historic and Forecast Sales by Regions

11 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY SALES CHANNEL

  • 11.1 Overview by Sales Channel
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Sales Channel
  • 11.4 Online Sales Historic and Forecast Sales by Regions
  • 11.5 Institutional Sales Historic and Forecast Sales by Regions
  • 11.6 Retail Sales Historic and Forecast Sales by Regions

12 . GLOBAL ENTERAL FEEDING FORMULAS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE ENTERAL FEEDING FORMULAS COMPANIES

  • 13.1. Enteral Feeding Formulas Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF ENTERAL FEEDING FORMULAS INDUSTRY

  • 14.1. Top Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Abbott
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. Danone SA
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. Fresenius Kabi
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. Nestle
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Victus Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Primus Pharmaceuticals Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. Meiji Holdings. Co. Ltd
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Rickett Benckiser Group Plc.
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies